IP Library Granted Patent US 10,183,901
Granted Patent B2
US 10,183,901 · App. 15/458,907 · Granted Jan 22, 2019

Stabilization and hydrogenation methods for microbial-derived olefins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,183,901
App. No.
15/458,907
Granted
Jan 22, 2019
Kind
B2
Abstract

Methods and compositions for stabilization and subsequent hydrogenation of a microbial-derived immiscible olefin are described. The methods comprise separating immiscible olefin from a mixture comprising an aqueous solution, microbial cells and immiscible olefin thereby forming a crude olefin composition; purifying the crude olefin composition thereby forming a purified olefin composition; and adding a phenolic antioxidant to the purified olefin composition wherein the phenolic antioxidant is a phenol derivative containing an unfused phenyl ring with one or more hydroxyl substituents. The methods further comprise reacting the purified olefin composition with hydrogen in the presence of a hydrogen catalyst such that hydrogen saturates at least one double bond in the olefin. Hydrogenated compositions produced by the methods are further provided.

Claims (30)

1. A hydrogenated composition derived from a microbial derived olefin composition, the hydrogenated composition produced by a method comprising:

(a) separating immiscible olefin from a mixture comprising an aqueous solution, microbial cells and immiscible olefin, thereby forming a crude olefin composition;

(b) purifying the crude olefin composition thereby forming a purified olefin composition;

(c) adding a phenolic antioxidant to the purified olefin composition to form a stabilized purified microbial-derived olefin composition, wherein the phenolic antioxidant is a phenol derivative containing an unfused phenyl ring with one or more hydroxyl substituents, and is present in an amount that is at least 0.0001% by weight of stabilized purified microbial-derived olefin composition; and

(d) reacting the stabilized purified microbial-derived olefin composition with hydrogen in the presence of a hydrogenation catalyst at a temperature at or greater than about 20° C. such that hydrogen saturates at least one double bond in the olefin, thereby producing the hydrogenated composition.

2. The hydrogenated composition of claim 1 , wherein the method further comprises adding a phenolic antioxidant to the crude olefin composition.

3. The hydrogenated composition of claim 1 , wherein the purification step comprises removing or reducing monoglycerides, diglycerides, ergosterol, squalene, or any combination thereof from the crude olefin composition.

4. The hydrogenated composition of claim 1 , wherein the phenolic antioxidant is selected from the group consisting of 3-tert-butyl-4-hydroxyanisole; 2-tert-butyl-4-hydroxyanisole; 2,4,-dimethyl-6-tert-butylphenol; and 2,6-di-tert-butyl-4-methylphenol.

5. The hydrogenated composition of claim 1 , wherein the phenolic antioxidant is a catechol.

6. The hydrogenated composition of claim 1 , wherein the phenolic antioxidant is 4-tert-butyl catechol.

7. The hydrogenated composition of claim 1 , wherein the phenolic antioxidant is present in at least about 0.001% by weight of the stabilized purified microbial-derived olefin composition.

8. The hydrogenated composition of claim 1 , wherein the phenolic antioxidant is present in at least about 0.005% by weight of the stabilized purified microbial-derived olefin composition.

9. The hydrogenated composition of claim 1 , wherein the phenolic antioxidant is present in at least about 0.01% by weight of the stabilized purified microbial-derived olefin composition.

10. The hydrogenated composition of claim 1 , wherein the hydrogenation reaction occurs at a temperature that is greater than about 100° C.

11. The hydrogenated composition of claim 1 , wherein the hydrogenated composition comprises a partially hydrogenated immiscible olefin.

12. The hydrogenated composition of claim 1 , wherein the microbial-derived olefin is a C 5 -C 20 isoprenoid.

13. The hydrogenated composition of claim 1 , wherein the microbial-derived olefin is a C 10 -C 15 isoprenoid.

14. The hydrogenated composition of claim 1 , wherein the stabilized purified microbial-derived olefin comprises farnesene in at least about 50%, 60%, 70%, 80%, 90%, 93%, 95%, 97%, 99% or greater by weight of the immiscible olefin.

15. The hydrogenated composition of claim 14 , wherein the hydrogenation reaction comprises selective hydrogenation of farnesene to reduce one, two, three, or four double bonds in farnesene.

16. The hydrogenated composition of claim 15 , wherein farnesene is selectively hydrogenated to reduce one double bond.

17. The hydrogenated composition of claim 15 , further comprising bisabolane in an amount that is equal to or greater than 0.1% by weight of the hydrogenated composition.

18. A hydrogenated composition derived from a microbial-derived olefin composition, the hydrogenated composition produced by a method comprising:

reacting a stabilized purified microbial-derived olefin composition with hydrogen in the presence of a hydrogenation catalyst, wherein the stabilized purified microbial-derived olefin composition comprises:

(a) farnesene in an amount that is at least equal to or greater than about 90% by weight of the stabilized purified microbial-derived olefin composition;

(b) bisabolene in an amount that is equal to or greater than about 0.1% by weight of the stabilized purified microbial-derived olefin composition;

(c) zingibrene in an amount that is equal to or greater than about 0.1% by weight of the stabilized purified microbial-derived olefin composition; and

(d) a phenolic antioxidant, wherein the phenolic antioxidant is a phenol derivative containing an unfused phenyl ring with one or more hydroxyl substituents in an amount that is at least about 0.005% by weight of the stabilized purified microbial-derived olefin composition,

wherein the hydrogenation reaction saturates at least one double bond in farnesene.

19. The hydrogenated composition of claim 18 , wherein the hydrogenated composition further comprises at least about 0.1% bisabolane by the weight of the hydrogenated composition.

20. The hydrogenated composition of claim 18 , wherein the hydrogenated composition comprises a partially hydrogenated farnesene.

Assignments (11)
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2023
From: SCHOTTENFELD OPPORTUNITIES FUND II, L.P.
To: AMYRIS, INC.
Reel/Frame 062304/0044 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2023
From: NAXYRIS S.A.
To: AMYRIS, INC.
Reel/Frame 062310/0378 →
CHANGE OF NAME Recorded Nov 15, 2022
From: AMYRIS BIOTECHNOLOGIES, INC.
To: AMYRIS, INC.
Reel/Frame 061940/0156 →
CHANGE OF NAME Recorded Nov 11, 2022
From: AMYRIS BIOTECHNOLOGIES, INC.
To: AMYRIS, INC.
Reel/Frame 061931/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2022
From: OHLER, NICHOLAS L.; VAZQUEZ, ROBERTO
To: AMYRIS BIOTECHNOLOGIES, INC.
Reel/Frame 061713/0832 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
GRANT OF PATENT SECURITY INTEREST Recorded Nov 20, 2019
From: AMYRIS, INC.
To: SCHOTTENFELD OPPORTUNITIES FUND II, L.P.
Reel/Frame 051072/0310 →
SECURITY INTEREST Recorded Aug 16, 2019
From: AMYRIS, INC.
To: NAXYRIS S.A.
Reel/Frame 050081/0106 →